Larvol Delta - ASLAN-Pharmaceuticals-Announces-Publication-in-Clinical-Immunology-Highlighting-Eblasakimabs-Unique-Mechanism-of-Action-in-the-Treatment-of-Atopic-Dermatitis

eblasakimab (ASLAN004) - ASLAN Pharma, Zenyaku Holdings

https://www.globenewswire.com/news-release/2023/06/23/2693589/0/en/ASLAN-Pharmaceuticals-Announces-Publication-in-Clinical-Immunology-Highlighting-Eblasakimab-s-Unique-Mechanism-of-Action-in-the-Treatment-of-Atopic-Dermatitis.html

Jun 23, 2023

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next